Claire Harrison, MD, DM, FRCP, FRCPath is a Professor of Hematology at the Guy’s and St. Thomas’ NHS Foundation Trust, London, UK.
Prof. Harrison became a consultant at the Guy’s and St. Thomas’ NHS Foundation Trust in 2001, where she is also now a Clinical Director. The focus of her work is to improve diagnosis, risk definition and therapy of myeloproliferative neoplasms (MPNs), for which she has a national and international reputation.
Prof. Harrison is chief investigator of several trials, including COMFORTII – the first JAK inhibitor trial in Europe. In 2011, she took over as chair of the NCRI MPD group. Prof. Harrison works on translational work and clinical trials, and collaborates internationally with many centres including Addenbrooke’s, Mayo and Mount Sinai. She has a national role in blood transfusion and also supports transfusion-based research.
She is an active user of Twitter, @harrisoncn1, where she shares inspiring updates on the latest work in MPNs.